The 60-year-old tells the BBC she suspects the government poster used a doctored picture of her.
A third woman has said she thinks her picture may have been used for a Spanish "beach body" advertising campaign without her permission.
One of the complaints came on Friday. On Saturday another woman featured on the poster said her prosthetic leg had been edited out.Sixty-year-old Ms FitzPatrick, from southern England, said the face of the woman who had a mastectomy could be based on one of her pictures. What happened "seems to be totally against" the theme of the campaign, she added. "For me it is about how my body has been used and represented without my permission."Juliet FitzPatrick was diagnosed with breast cancer in 2016 and is now cancer-free
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope - Cancer Cell InternationalCancer is one of the major causes of mortality worldwide, therefore it is considered a major health concern. Breast cancer is the most frequent type of cancer which affects women on a global scale. Various current treatment strategies have been implicated for breast cancer therapy that includes surgical removal, radiation therapy, hormonal therapy, chemotherapy, and targeted biological therapy. However, constant effort is being made to introduce novel therapies with minimal toxicity. Gene therapy is one of the promising tools, to rectify defective genes and cure various cancers. In recent years, a novel genome engineering technology, namely the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein-9 (Cas9) has emerged as a gene-editing tool and transformed genome-editing techniques in a wide range of biological domains including human cancer research and gene therapy. This could be attributed to its versatile characteristics such as high specificity, precision, time-saving and cost-effective methodologies with minimal risk. In the present review, we highlight the role of CRISPR/Cas9 as a targeted therapy to tackle drug resistance, improve immunotherapy for breast cancer.
Read more »
Belfast cancer survivor opens up on receiving diagnosis as a childDespite her challenges, the now 20-year-old is feeling optimistic about the future as she puts her all into sailing
Read more »
'I'm not dying, but I have bad news': How MP broke news she had breast cancer‘I’m not dying, but I have some bad news’ Dawn Butler (DawnButlerBrent) has opened up about one of the toughest parts of her cancer diagnosis – trying to tell her loved ones without worrying them. FindTheMillion
Read more »
Daily Insulin Dose and Cancer Risk Among Patients With Type 1 DiabetesThis cohort study examines the incidence of cancer diagnosis and risk factors among patients on a daily regimen of insulin.
Read more »
Cancer scared me so much - it's amazing to be all-clear, reveals Sam FoxPAGE Three favourite Sam Fox has told how a “weight has been lifted” after being given the all-clear following her cancer scare. Sam, who first appeared in The Sun in 1983 and is now a singer, had …
Read more »
The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer - Journal of Hematology & OncologyMitochondria are essential for tumor growth and progression. However, the heavy demand for mitochondrial activity in cancer leads to increased production of mitochondrial reactive oxygen species (mtROS), accumulation of mutations in mitochondrial DNA, and development of mitochondrial dysfunction. If left unchecked, excessive mtROS can damage and unfold proteins in the mitochondria to an extent that becomes lethal to the tumor. Cellular systems have evolved to combat mtROS and alleviate mitochondrial stress through a quality control mechanism called the mitochondrial unfolded protein response (UPRmt). The UPRmt system is composed of chaperones and proteases, which promote protein folding or eliminate mitochondrial proteins damaged by mtROS, respectively. UPRmt is conserved and activated in cancer in response to mitochondrial stress to maintain mitochondrial integrity and support tumor growth. In this review, we discuss how mitochondria become dysfunctional in cancer and highlight the tumor-promoting functions of key components of the UPRmt.
Read more »